Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma

Nat Rev Neurol. 2014 Apr;10(4):179. doi: 10.1038/nrneurol.2014.47. Epub 2014 Mar 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Dacarbazine / analogs & derivatives*
  • Female
  • Glioblastoma / drug therapy*
  • Humans
  • Male

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Dacarbazine